Post-mastectomy radiotherapy: Recommended standards

Annals of Oncology

Volumn 11, Issue SUPPL. 3, 2000, Pages 7-11

  Bartelink, H ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; MASTECTOMY; PHYSICIAN ATTITUDE; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; SKIN MANIFESTATION; STANDARD; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033775125     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_3.7     Document Type: Conference Paper

References (18)

1. Breast cancer evaluation of postoperative radiotherapy
2. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Group DCG 82b randomised trial
3. Postoperative radiotherapy in high-risk postmenopausal patients given adjuvant tamoxifen: Danish Breast Cancer Group DBCG 82c randomised trial
4. Adjuvant radiotherapy and chemotherapy in node positive premenopausal women with breast cancer
5. Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy
6. Radiotherapy-related lung fibrosis enhanced by tamoxifen
7. Estimation of cardiac and lung complications after breast cancer irradiation
8. Importance of timing of radiotherapy in breast conserving treatment of early stage breast cancer
9. Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: A European Organization for Research and Treatment of Cancer randomized phase III trial
10. High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer, Breast Cancer Cooperative Group Study
11. The effects of sequence and type of chemotherapy and radiation therapy on cosmesis and complications after breast conservation therapy
12. Does the sequence of radiotherapy and chemotherapy in breast-conserving therapy influence outcome?
13. Frequency of first metastatic events in breast cancer: Implications for sequencing of systemic and local-regional treatment
14. Cause-specific mortality on long-term survivors of breast cancer who participated in trials of radiotherapy
15. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
16. Postmastectomy radiotherapy: Questions for the twenty-first century
17. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials
18. Radiotherapy for early breast cancer: Was a comprehensive overview of trials needed?